written by Ehab A. M. Elagab, Majed Alshahrani, Amin A. A. Elbadawi, Abdullah I. Aedh, Ahmed M. Osman, Hanadi M. Osman, ...

Researchers at the University of Adelaide's Robinson Research Institute have uncovered a new critical role for the immune ...

Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...

Creating cancer therapies based around natural killer cells could offer similar levels of efficacy to CAR-T therapies, but at around one hundredth of the cost. Researchers at MD Anderson Cancer ...

For the new therapy, these cells are derived from stem cells that originated from healthy adult donor tissue - called induced pluripotent stem cells (iPSCs) - to make therapeutic CAR-NK cells.

Immunotherapy, especially therapy based on natural killer (NK) cells, presents a promising avenue for the treatment of PDAC. Aims: This research endeavor seeks to formulate a predictive tool ...

4Research Unit of NK Cell Study, Chinese Academy of Medical Sciences, Beijing, China. Search for other works by this author on: 1Biomedical Sciences and Health Laboratory of Anhui Province, Division ...

Applying chimeric antigen receptor (CAR) technology to natural killer (NK) cells may offer safe, effective, and affordable therapies that enhance cancer immune surveillance. Methods: Here, we assess ...

1Masonic Cancer Center, Minneapolis, Minnesota. 6Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota. 7Department of ...

Jan. 31, 2025 — Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders -- T cells -- lose their ability to ...